Health Europa
Researchers from the Singapore-MIT Alliance for Research and Technology (SMART) Critical Analytics for Manufacturing Personalized Medicine (CAMP) research group have been awarded new research grants aimed at supporting work exploring personalized medicine and cell therapy, reports Health Europa. “In addition to our existing research on our three flagship projects, we hope to develop breakthroughs in manufacturing other cell therapy platforms that will enable better medical treatments and outcomes for society,” says Associate Provost Krystyn Van Vliet.